Product Code: ETC7657786 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Opiods Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Opiods Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Opiods Drug Market - Industry Life Cycle |
3.4 Israel Opiods Drug Market - Porter's Five Forces |
3.5 Israel Opiods Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Opiods Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Opiods Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Opiods Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Israel |
4.2.2 Growing awareness and acceptance of opioid medications for pain management |
4.2.3 Rising geriatric population in Israel leading to higher demand for pain relief medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies governing opioid prescribing and dispensing in Israel |
4.3.2 Concerns about opioid abuse, addiction, and overdose in the country |
5 Israel Opiods Drug Market Trends |
6 Israel Opiods Drug Market, By Types |
6.1 Israel Opiods Drug Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Opiods Drug Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Opiods Drug Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.4 Israel Opiods Drug Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.5 Israel Opiods Drug Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.1.6 Israel Opiods Drug Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.7 Israel Opiods Drug Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.1.8 Israel Opiods Drug Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.2 Israel Opiods Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Opiods Drug Market Revenues & Volume, By Pain Relief, 2021- 2031F |
6.2.3 Israel Opiods Drug Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.4 Israel Opiods Drug Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.2.5 Israel Opiods Drug Market Revenues & Volume, By Diarrhea Suppression, 2021- 2031F |
6.2.6 Israel Opiods Drug Market Revenues & Volume, By Deaddiction, 2021- 2031F |
6.3 Israel Opiods Drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Opiods Drug Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Opiods Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Opiods Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 Israel Opiods Drug Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.6 Israel Opiods Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Opiods Drug Market Import-Export Trade Statistics |
7.1 Israel Opiods Drug Market Export to Major Countries |
7.2 Israel Opiods Drug Market Imports from Major Countries |
8 Israel Opiods Drug Market Key Performance Indicators |
8.1 Number of prescriptions for opioids issued by healthcare providers in Israel |
8.2 Rate of opioid-related hospital admissions and emergency room visits |
8.3 Percentage of healthcare professionals trained in safe opioid prescribing practices |
9 Israel Opiods Drug Market - Opportunity Assessment |
9.1 Israel Opiods Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Opiods Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Opiods Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Opiods Drug Market - Competitive Landscape |
10.1 Israel Opiods Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Opiods Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |